The Federal Trade Commission has started cracking down on digital health companies for allegedly sharing consumers’ health data for advertising purposes.
Last month, the agency said GoodRx had shared personal health information with third parties like Google and Facebook. The company, best known for its drug-cost transparency tools, agreed to pay a $1.5 million fine to settle the case, but admitted no wrongdoing.
And just yesterday, the FTC announced a proposed order that would bar online therapy company BetterHelp from disclosing health data for advertising, including $7.8 million in payments to consumers whose data was shared. BetterHelp also admitted no wrongdoing, and noted that it had settled regarding alleged practices in place several years ago.
Scott Loughlin, a partner at Hogan Lovells who also leads the law firm’s global privacy and cybersecurity practice, sat down with MobiHealthNews to discuss the agency’s enforcement action against GoodRx and what digital health companies should learn from the case.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Mobihealth News
